Skip to main content
Terug
Watch Compare

Zepp Health Corp

Datakwaliteit: 100%
ZEPP
NYSE Technology Consumer Electronics
€ 14,01
▼ € 0,11 (-0,78%)
6 months return
—
Momentum
Neutral
5Y revenue growth
-34,40%

Groei

Revenue Growth (5Y)
-34,40%
Onder sectorgemiddelde (7,29%)
Revenue (1Y)-48,04%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-25,13%
Onder sectorgemiddelde (1,56%)
ROIC-9,18%
Net Margin-41,47%
Op. Margin-25,88%

Veiligheid

Debt / Equity
0,30
Onder sectorgemiddelde (0,41)
Current Ratio1,29
Interest Coverage-8,51

Waardering

PE (TTM)
-2,40
Onder sectorgemiddelde (-0,16)
P/B Ratio0,72
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Revenue declined -34,40% annually over 5 years
Debt/Equity of 0,30 — conservative balance sheet
Negative free cash flow of -25,80 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 13,64%
Capital efficient — spends only 0,77% of revenue on capex

Price History

Financiële Trends

Koersdoel Analisten

1 analist
Hold
+359.5%
upside to target
Huidig
€ 14,01
Consensus Target
€ 64,37
€ 64,37
Laag
€ 64,37
Hoog
Vooruitzicht
Forward WPA
-€ 0,01
Omzet Sch.
0,0

Growth

Rev 5Y: -34,40% · Earnings 1Y: N/A
Revenue Growth (1Y) -48,04% Revenue Growth (3Y) -44,86%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -34,40% Earnings Growth (5Y) N/A

Profitability

ROE: -25,13% · Net Margin: -41,47%
Revenue (TTM) 182,60 M Net Income (TTM) -75,73 M
ROE -25,13% ROA -13,01%
Gross Margin 38,46% Operating Margin -25,88%
Net Margin -41,47% Free Cash Flow (TTM) -25,80 M
ROIC -9,18% FCF Growth (3Y) N/A

Safety

D/E: 0,30 · Current: 1,29
Debt / Equity 0,30 Current Ratio 1,29
Interest Coverage -8,51 Asset Turnover 0,31
Working Capital 56,20 M Tangible Book Value 234,92 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years 1 yrs

Valuation

P/E: -2,40 · EV/EBITDA: N/A
P/E Ratio -2,40 Forward P/E N/A
P/B Ratio 0,72 P/S Ratio 1,00
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -14,18%
Market Cap 181,93 M Enterprise Value 166,11 M

Per Share

EPS: -0,29 · FCF/Share: -1,76
EPS (Diluted TTM) -0,29 Revenue / Share 12,49
FCF / Share -1,76 OCF / Share -1,67
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 34,06% · CapEx/Rev: 0,77%
CapEx / Revenue 0,77% FCF Conversion 34,06%
SBC-Adj. FCF -30,57 M Growth Momentum -13,64

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 182,60 M 351,46 M 600,66 M 980,78 M 985,96 M
Net Income -75,73 M -29,88 M -41,80 M 21,62 M 35,06 M
EPS (Diluted) -0,29 -0,12 -0,17 0,08 0,13
Gross Profit 70,23 M 92,65 M 116,44 M 204,88 M 204,24 M
Operating Income -47,25 M -29,17 M -59,48 M 14,74 M 26,70 M
EBITDA — — — — —
R&D Expenses 46,16 M 50,96 M 74,98 M 80,83 M 82,45 M
SG&A Expenses — — — — —
D&A 5,02 M 7,67 M 8,50 M 8,14 M 4,16 M
Interest Expense 5,55 M 6,72 M 8,26 M 7,04 M 7,07 M
Income Tax 13,69 M -2,23 M -9,55 M 1,69 M 4,78 M

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 528,59 M 635,52 M 763,74 M 954,95 M 904,79 M
Total Liabilities 275,87 M 282,77 M 374,46 M 494,63 M 486,35 M
Shareholders' Equity 251,59 M 351,07 M 387,48 M 458,27 M 418,43 M
Total Debt 75,24 M 120,02 M 99,20 M 114,06 M 9,20 M
Cash & Equivalents 91,07 M 133,67 M 128,55 M 230,44 M 348,41 M
Current Assets 251,56 M 316,73 M 428,95 M 616,85 M 739,90 M
Current Liabilities 195,37 M 155,11 M 241,93 M 337,72 M 427,54 M

Sectorvergelijking

vs Technology sector mediaan (1234 peers)
Metriek Aandeel Sector Mediaan
P/E -2,4 -0,2
P/B 0,7 3,0
ROE % -25,1 1,6
Net Margin % -41,5 -0,5
Rev Growth 5Y % -34,4 7,3
D/E 0,3 0,4

Dividendgeschiedenis

Recente betalingen per aandeel (nieuwste eerst).

Ex-dividend Betaling Bedrag / aandeel
Mar 25, 2022 — € 0,40